Total Payments
$6,062
2024 Payments
$1,344
Companies
32
Transactions
198
Medicare Patients
1,615
Medicare Billing
$77,250
Payment Breakdown by Category
Food & Beverage$5,035 (83.1%)
Travel$983.64 (16.2%)
Consulting$33.92 (0.6%)
Education$9.01 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,035 | 191 | 83.1% |
| Travel and Lodging | $983.64 | 3 | 16.2% |
| Consulting Fee | $33.92 | 1 | 0.6% |
| Education | $9.01 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HEARTFLOW, INC. | $1,407 | 11 | $0 (2024) |
| Boston Scientific Corporation | $569.19 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $525.53 | 28 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $424.36 | 15 | $0 (2024) |
| Abbott Laboratories | $388.21 | 4 | $0 (2018) |
| Amgen Inc. | $348.77 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $298.54 | 18 | $0 (2024) |
| PFIZER INC. | $214.63 | 13 | $0 (2024) |
| ABIOMED | $195.05 | 4 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $188.59 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,344 | 54 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($337.67) |
| 2023 | $2,201 | 37 | HeartFlow, Inc. ($1,369) |
| 2019 | $260.69 | 15 | Boston Scientific Corporation ($93.06) |
| 2018 | $1,216 | 44 | Abbott Laboratories ($229.38) |
| 2017 | $1,041 | 48 | Amgen Inc. ($247.53) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $88.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $174.05 | General |
| 11/21/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.69 | General |
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $41.21 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/22/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.23 | General |
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $36.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 540 | 573 | $99,179 | $29,189 |
| 2022 | 15 | 1,020 | 1,291 | $152,243 | $46,984 |
| 2021 | 2 | 55 | 66 | $4,636 | $1,078 |
Total Patients
1,615
Total Services
1,930
Medicare Billing
$77,250
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 251 | 257 | $55,377 | $12,311 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 83 | $15,262 | $6,848 | 44.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 38 | $9,332 | $3,655 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,292 | $2,007 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 28 | $3,704 | $1,701 | 45.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 30 | 30 | $5,826 | $1,334 | 22.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 55 | $2,579 | $512.49 | 19.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 31 | 31 | $1,147 | $500.96 | 43.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 30 | 30 | $660.00 | $320.40 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $25,287 | $10,356 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 95 | $18,816 | $8,680 | 46.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 163 | 163 | $25,881 | $8,227 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $13,775 | $5,440 | 39.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 77 | $10,437 | $4,248 | 40.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 364 | 576 | $27,218 | $3,443 | 12.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 48 | 48 | $10,243 | $2,712 | 26.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,416 | $1,676 | 38.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 68 | 68 | $4,441 | $746.89 | 16.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 32 | 32 | $3,006 | $508.03 | 16.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 32 | 32 | $5,298 | $338.79 | 6.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 17 | 17 | $1,082 | $313.20 | 28.9% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 12 | 12 | $1,122 | $160.30 | 14.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 17 | 17 | $337.00 | $89.97 | 26.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 18 | 18 | $884.00 | $42.87 | 4.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 13 | 13 | $2,145 | $731.77 | 34.1% |
About Dr. Patrick Hickle, MD
Dr. Patrick Hickle, MD is a Cardiovascular Disease healthcare provider based in Manchester, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346218609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Hickle, MD has received a total of $6,062 in payments from pharmaceutical and medical device companies, with $1,344 received in 2024. These payments were reported across 198 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,035).
As a Medicare-enrolled provider, Hickle has provided services to 1,615 Medicare beneficiaries, totaling 1,930 services with total Medicare billing of $77,250. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Manchester, NH
- Active Since 03/10/2006
- Last Updated 07/10/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1346218609
Products in Payments
- FFRct (Device) $1,407
- XARELTO (Drug) $525.53
- LifeVest (Device) $424.36
- Mitra Clip system (Device) $229.38
- BRILINTA (Drug) $205.02
- Impella (Device) $195.05
- Repatha (Biological) $191.50
- RESONATE (Device) $170.54
- CHANTIX (Drug) $164.30
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $157.00
- Corlanor (Drug) $148.83
- Barostim Neo System (Device) $147.90
- WATCHMAN FLX (Device) $136.30
- Xience Alpine cornary stent system (Device) $120.54
- KENGREAL (Drug) $120.50
- OPSUMIT MACITENTAN (Drug) $101.92
- JARDIANCE (Drug) $95.86
- FARXIGA (Drug) $93.52
- ENTRESTO (Drug) $92.51
- ELIQUIS (Drug) $92.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Manchester
Dr. Fahad Gilani, M.d, M.D
Cardiovascular Disease — Payments: $389,229
Cardiovascular Disease $389,229
Dr. Robert Capodilupo, M.d, M.D
Cardiovascular Disease — Payments: $180,535
Cardiovascular Disease $180,535
Dr. Stephan Heo, M.d, M.D
Cardiovascular Disease — Payments: $97,578
Cardiovascular Disease $97,578
Jeanney Lew, M.d, M.D
Cardiovascular Disease — Payments: $18,141
Cardiovascular Disease $18,141
Dr. Jinu John, M.d, M.D
Cardiovascular Disease — Payments: $15,879
Cardiovascular Disease $15,879
Mr. Venkateswara Narla, Md, MD
Cardiovascular Disease — Payments: $9,752
Cardiovascular Disease $9,752